OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 28, 2020
Delivery will commence over the course of two months following the EUA and the government will have the ability to purchase up to 650,000 additional vials of the treatment through June 30, 2021 based on product availability and medical need.
September 18, 2020
The collaboration will expand the manufacturing capacity for lenzilumab, a COVID-19 therapeutic candidate, in advance of a potential Emergency Use Authorization in 2020.
The agreement between the two companies will significantly increase global supply capacity for Lilly's potential COVID-19 treatments.
September 01, 2020
As technology matures, inefficiencies and process limitations in downstream process chromatography are improved.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 01, 2020
It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.
Glycoengineering is growing in importance as a technique to improve antibody therapeutic efficacy, safety, and product quality.
July 21, 2020
GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.
July 08, 2020
BARDA and DOD have awarded a $450-million contract to Regeneron Pharmaceuticals to manufacture and supply an investigational double antibody cocktail in development for treating COVID-19.